Approach to encephalopathy in infants

Reading File

Finding Sources

Searching PubMed

neonatal encephalopathy diagnosis management

Reading File

Finding Sources

Reading File

Searching Images

neonatal encephalopathy Sarnat staging MRI brain hypoxic ischemic

This diagnostic image consists of two brain MRI panels (axial and sagittal views) illustrating severe neonatal hypoxic-ischemic encephalopathy (HIE). The left panel is an axial T2-weighted or FLAIR sequence showing symmetric, bilateral hyperintensities (increased signal) within the basal ganglia (putamen and globus pallidus) and the thalamus, marked by red arrows. This 'basal ganglia-thalamus pattern' is characteristic of acute profound asphyxia. The right panel is a sagittal view showing an area of increased signal intensity and subtle swelling in the dorsal brainstem, specifically in the region of the pons/medulla junction near the vestibulocochlear nerve nuclei. These findings are clinically significant as they correlate with Stage III Sarnat HIE and are associated with profound sensorineural hearing impairment and poor neurological outcomes in neonates.

Diagnostic axial MRI images of a neonatal brain demonstrating pathological changes associated with hypoxic-ischemic encephalopathy (HIE) and white matter injury. The image panel contains two T1-weighted sequences and one T2-weighted sequence. On the T1-weighted images (left and center), red circles highlight multiple small, punctate hyperintensities located within the periventricular and subcortical white matter of the frontal and temporal lobes, characteristic of focal white matter lesions. On the T2-weighted image (right), a white square demarcates a region of diffuse excessive high signal intensity (DEHSI) in the posterior periventricular white matter, primarily involving the occipital region. This T2-hyperintensity is indicative of increased water content, such as vasogenic edema or dysmyelination. These imaging findings represent common neuroradiological markers for neonatal seizures and subsequent neurodevelopmental risks following hypoxic-ischemic events.

This diagnostic image displays side-by-side coronal (left) and sagittal (right) cranial ultrasound views of a neonate. The imaging shows findings characteristic of severe hypoxic-ischemic encephalopathy (HIE), specifically Sarnat stage III. Both views demonstrate diffuse, markedly increased echogenicity involving the cerebral cortex and deep gray matter structures. Specifically, white stars mark the bilateral thalamic and basal ganglia regions, which appear hyperechoic compared to normal neonatal brain tissue. Significant cerebral edema is present, resulting in a loss of normal anatomical definition and the compression of the lateral ventricles, which are slit-like or barely visible. These visual markers indicate profound global ischemic injury and are critical for the bedside evaluation of neurodevelopmental prognosis in neonatal intensive care. The image serves as a teaching tool for recognizing sonographic patterns of acute perinatal asphyxia and diffuse brain swelling.

Reading File

I now have comprehensive information to write a thorough, well-structured answer. Let me compile it.

Approach to Encephalopathy in Infants

Definition

Neonatal encephalopathy (NE) is defined as a condition occurring in babies born at more than 35 weeks' gestational age in which there is disturbed neurological function - particularly in the degree or quality of consciousness. Co-occurring features include seizures and abnormal tone, movements, and reflexes, though these are not required for the diagnosis. The incidence is approximately 1-6 per 1,000 live births, with a mortality rate of ~20% and neurodevelopmental disability in ~25% of survivors.

Bradley and Daroff's Neurology in Clinical Practice (line 1269)
Adams and Victor's Principles of Neurology, 12th Ed. (line 1372)

Etiology (Causes by Category)

1. Hypoxic-Ischemic (Most Common)

Hypoxic-ischemic encephalopathy (HIE) results from reduced blood flow and oxygen delivery to the brain, often from impaired placental gas exchange. Risk factors and precipitants include:

Antenatal: Gestational diabetes, intrauterine growth restriction (IUGR), preeclampsia, pregnancy-induced hypertension, antepartum hemorrhage, maternal hypotension, hypothyroidism

Intrapartum: Reduced fetal movements, non-reassuring fetal heart rate, placental abruption, cord prolapse/accident, meconium-stained fluid, emergency cesarean, low cord pH, low Apgar scores, need for resuscitation

The regions most vulnerable are those with greatest metabolic demand: Rolandic cortex, thalamus, and basal ganglia.

2. Metabolic

Hypoglycemia - most immediately treatable cause; must be excluded in all encephalopathic infants
Hypocalcemia, hyponatremia, hypomagnesemia - electrolyte abnormalities causing seizures/encephalopathy
Inborn errors of metabolism (IEM) - typically present 2-3 days after birth once feeding begins (organic acidemias, urea cycle defects, maple syrup urine disease, non-ketotic hyperglycinemia)
Pyridoxine (B6) deficiency - important cause of neonatal seizures, treatable with pyridoxine
Hyperbilirubinemia/kernicterus - prematurity, acidosis, and prior hypoxic-ischemic injury predispose to bilirubin neurotoxicity, causing staining of specific nuclei

3. Infectious

Bacterial meningitis/sepsis - GBS, E. coli, Listeria in neonates
Viral encephalitis - HSV (herpes simplex), enterovirus, CMV
TORCH infections - congenital infections presenting with encephalopathy from birth

4. Structural / Vascular

Perinatal arterial ischemic stroke (PAIS) - focal clonic seizures, often in left MCA territory
Cerebral sinovenous thrombosis (CSVT)
Neonatal hemorrhagic stroke
Congenital CNS malformations
Periventricular leukomalacia - especially in preterm infants
Cerebellar hemorrhage - in preterm infants, from germinal matrix rupture

5. Toxic/Drug-Related

Neonates born to mothers using cocaine, heroin, or ethanol - drug-withdrawal encephalopathy/seizures in the first few days of life
Harrison's Principles of Internal Medicine 22E (line 1430)

Clinical Assessment

Signs of Encephalopathy in Infants

The key features of cerebral dysfunction are encephalopathy and seizures. Specific signs:

Feature	Significance
Altered consciousness (excessive drowsiness or inability to maintain wakefulness)	Core marker - full-term infants should spend some time awake with eyes open
Excessive irritability	Cortical irritation
Poor feeding / absent suck	Encephalopathy or brainstem dysfunction
Hypotonia with relatively preserved power	Central (not peripheral) cause
Fisting (thumb trapped in closed hand)	Central dysfunction
Normal/brisk tendon reflexes	Favors central over peripheral cause
Absent/abnormal primitive reflexes (Moro, ATNR)	Degree of encephalopathy
Seizures (focal, multifocal, subtle)	Cortical irritation
Abnormal posturing (decerebrate/decorticate)	Severe encephalopathy

Distinguishing central from peripheral hypotonia: Central causes show encephalopathy + seizures + normal power + brisk reflexes. Peripheral causes show alert infant, absent reflexes, and weakness proportional to tone deficit.

Bradley and Daroff's Neurology in Clinical Practice (lines 2133-2135)

Staging of HIE - Sarnat Classification

Category	Mild (Stage 1)	Moderate (Stage 2)	Severe (Stage 3)
Consciousness	Hyperalert, wide-open eyes	Lethargic, obtunded	Stupor/coma
Spontaneous activity	Normal	Decreased	Absent
Tone	Mild distal flexion	Decreased, hypotonic	Flaccid
Muscle stretch reflexes	Increased	Decreased	Absent
Suck	Decreased	Decreased	Absent
Moro reflex	Increased	Decreased	Absent
Clinical seizures	None	Present (++)	May be present (+)
EEG background	Normal	Abnormal	Severely abnormal/suppressed
Autonomic	Sympathetic predominance	Parasympathetic	Both depressed
Prognosis	Usually full recovery	Variable	High mortality/disability

Seizures in HIE typically appear during the secondary phase of injury, before 24 hours of life.

Additional scores in use: Thompson Encephalopathy Score, NICHD neurological exam, UCSF Encephalopathy Score.

Bradley and Daroff's Neurology in Clinical Practice, Table 110.3 (line 1311)

Investigations

Immediate / Bedside

Blood glucose - must be checked immediately; hypoglycemia is rapidly reversible
ABG/lactate - acidosis, elevated lactate supports HIE or metabolic disorder
Electrolytes (Na, Ca, Mg), renal and liver function
Full blood count, CRP/PCT, blood cultures - sepsis screen
Cord blood gas / Apgar scores - retrospective evidence of perinatal asphyxia

Laboratory

Ammonia, amino acids (plasma), organic acids (urine) - IEM screen
Urine toxicology - drug exposure
CSF analysis (cell count, glucose, protein, culture, HSV PCR) - infection/inflammation
Serum bilirubin - kernicterus risk
Thyroid function, lactate/pyruvate ratio, biotinidase
Chromosomal/genetic testing when malformation suspected

Electrophysiology

Amplitude-integrated EEG (aEEG) / continuous EEG monitoring - essential for seizure detection (many neonatal seizures are subclinical), EEG background pattern has prognostic value. Epileptiform activity and voltage suppression are associated with unfavorable outcomes.
Visual and auditory evoked potentials - poor prognostic signs when abnormal

Neuroimaging

Cranial ultrasound (CUS) - bedside, detects IVH, periventricular leukomalacia, large infarcts, gross cerebral edema. Limitations: misses posterior fossa, cortical, and small lesions.

MRI brain - gold standard. Two predominant injury patterns in term HIE:

Basal ganglia-thalamus (BGT) pattern - symmetric restriction on DWI in ventrolateral thalami and posterior putamina ± perirolandic cortex. Seen after acute profound asphyxia (e.g., cord prolapse). Correlates with severe outcome.
Watershed predominant pattern - restriction in anterior-MCA and posterior-MCA watershed zones (cortical and subcortical white matter). Seen with prolonged partial asphyxia.

Timing of MRI changes:

DWI restriction: begins soon after injury, peaks within a few days, "normalizes" by end of first week
T1/T2 changes: begin around day 3-4 (absence of normal high T1 signal in posterior limb of internal capsule is a key finding)
MR spectroscopy: elevated lactate:NAA ratio in deep gray nuclei has prognostic value

For neonatal stroke: DWI restriction appears within hours (unlike HIE where it may lag by days).

MRI showing basal ganglia-thalamus pattern in severe HIE - symmetric hyperintensities in putamen, globus pallidus, thalami on DWI

MRI (axial + sagittal): Stage III HIE with basal ganglia-thalamus pattern. Red arrows mark bilateral symmetric hyperintensities in basal ganglia and thalami, with brainstem involvement.

Periventricular white matter injury on MRI - neonatal

Neonatal MRI: Punctate periventricular white matter lesions (T1 hyperintense) and posterior DEHSI on T2, representing white matter injury after HIE.

Bradley and Daroff's Neurology in Clinical Practice (lines 1305-1320)

Management

1. Immediate Stabilization (ABC)

Secure airway; support breathing (many severe cases require mechanical ventilation)
Correct hypoglycemia immediately (IV dextrose)
Correct electrolyte abnormalities
Treat sepsis empirically (ampicillin + gentamicin ± acyclovir if HSV suspected) pending cultures
Avoid hyperthermia (worsens neuronal injury)

2. Therapeutic Hypothermia (HIE-specific, EVIDENCE-BASED)

Indication: Moderate or severe HIE (Sarnat stage 2 or 3), gestational age ≥36 weeks
Window: Must be initiated within 6 hours of birth
Target temperature: 33.5°C (whole-body cooling) for 72 hours, then slow rewarming
NNT = 7 to prevent one death or moderate-severe impairment
Despite hypothermia, mortality + morbidity in moderate-severe HIE remains nearly 50%
Adjuncts under study: erythropoietin (EPO), melatonin, allopurinol
Bradley and Daroff's Neurology in Clinical Practice (line 1326)

3. Seizure Management

First-line: Phenobarbital (20 mg/kg IV loading dose)
Second-line: Levetiracetam (gaining use as alternative/adjunct), phenytoin/fosphenytoin
Pyridoxine 100 mg IV if seizures unresponsive - trial for pyridoxine-dependent epilepsy
Continuous EEG monitoring - subclinical seizures are common and must be detected
Avoid prolonged seizures - they compound neuronal injury

4. Metabolic/IEM Management

Restrict protein if urea cycle defect suspected
Thiamine, biotin, cofactor trials in refractory neonatal seizures
Specific dietary/enzyme replacement therapies once IEM confirmed

5. Neuroprotective Supportive Care

Maintain normoglycemia (glucose 50-100 mg/dL)
Normotension (avoid hypotension)
Normocapnia (avoid hypo/hypercarbia - both worsen outcome)
Avoid hyperthermia
Treat hyperbilirubinemia promptly (phototherapy, exchange transfusion)

Prognosis

Stage	Outcome
Mild (Sarnat 1)	Full recovery in most
Moderate (Sarnat 2)	Variable - may improve by 48-72h or deteriorate with cerebral edema and seizures
Severe (Sarnat 3)	High mortality; survivors often have severe neurodevelopmental disability

Poor prognostic markers:

Seizures with EEG burst-suppression or flat background
Absent brainstem reflexes
Severe BGT pattern on MRI
Abnormal visual/auditory evoked potentials
Absent posterior limb of internal capsule signal on T1 MRI

Summary Algorithm

Infant with encephalopathy
    │
    ├── STABILIZE: Airway, breathing, circulation
    │
    ├── IMMEDIATE INVESTIGATIONS
    │       Blood glucose → treat hypoglycemia NOW
    │       ABG, electrolytes, ammonia, LFTs, CBC, cultures
    │       CSF (LP when stable)
    │
    ├── DETERMINE CAUSE
    │       Perinatal history → HIE?
    │       Fever/maternal illness → Infection?
    │       Onset after feeds → IEM?
    │       Drug exposure → Withdrawal?
    │       Dysmorphism/malformation → Structural/genetic?
    │
    ├── STAGE ENCEPHALOPATHY (Sarnat)
    │       EEG / aEEG monitoring
    │       MRI brain (preferably day 3-5)
    │
    └── TREAT
            HIE moderate/severe → Therapeutic hypothermia (within 6h)
            Seizures → Phenobarbital ± levetiracetam ± pyridoxine
            Infection → Antibiotics ± acyclovir
            IEM → Dietary restriction, cofactors
            Electrolyte → Correction

Sources:

Bradley and Daroff's Neurology in Clinical Practice (lines 1267-1332, 2131-2148)
Adams and Victor's Principles of Neurology, 12th Edition (lines 1372-1400)
Harrison's Principles of Internal Medicine 22E (line 1430)

This is a shared conversation. Sign in to Orris to start your own chat.